QQ客服 官方微博 反馈留言

浏览/检索结果: 共10条，第1-10条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Structurally diverse diterpenoid alkaloids from the lateral roots of Aconitum carmichaelii Debx. and their anti-tumor activities based on in vitro systematic evaluation and network pharmacology analysis 期刊论文 RSC ADVANCES, 2021, 卷号: 11, 期号: 43, 页码: 26594-26606 作者:  Yu, Yang;  Wu, Shifei;  Zhang, Jianqing;  Li, Jiayuan;  Yao, Changliang 收藏  |  浏览/下载：27/0  |  提交时间：2021/11/04 Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial 期刊论文 GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162 作者:  Yang, Jiaxin;  Wu, Xiaohua;  Zhu, Jianqing;  Song, Liang;  Feng, Yanling 收藏  |  浏览/下载：42/0  |  提交时间：2021/11/01 Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial 期刊论文 GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162 作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li 收藏  |  浏览/下载：49/0  |  提交时间：2021/11/01 Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer and a time-to-progression after penultimate platinum-based chemotherapy of 6-12 or > 12 months: a subgroup analysis of the phase III NORA trial 期刊论文 GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162 作者:  Huang, Qidan;  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Danqing;  Yang, Jiaxin 收藏  |  浏览/下载：42/0  |  提交时间：2021/11/01 Safety assessment of niraparib individualized starting dose in patients with platinum-sensitive recurrent ovarian cancer: A randomized, double-blind, placebo-controlled, phase III NORA trial. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Wang, Jing;  Wu, Xiaohua;  Zhu, Jianqing;  Yin, Rutie;  Yang, Jiaxin 收藏  |  浏览/下载：24/0  |  提交时间：2022/01/10 Efficacy of niraparib maintenance therapy in Chinese women with platinum-sensitive recurrent ovarian cancer with and without secondary cytoreductive surgery: Results from the NORA trial. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Wu, Lingying;  Wu, Xiaohua;  Zhu, Jianqing;  Yin, Rutie;  Yang, Jiaxin 收藏  |  浏览/下载：22/0  |  提交时间：2022/01/10 A sealed ceramic GEM-based neutron detector 期刊论文 NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2021, 卷号: 995, 页码: 6 作者:  Zhou, Jianjin;  Zhou, Jianrong;  Zhou, Xiaojuan;  Zhu, Lin;  Wei, Yangdong 收藏  |  浏览/下载：16/0  |  提交时间：2021/12/08 Sealed detector  Neutron detector  Ceramic GEM  Spallation neutron source   Nontargeted metabolomic analysis and multiple criteria decision-making method induced robust quality markers screening for the authentication of herbal medicines from different origins by taking Ophiopogon japonicus L. f. Ker-Gawl. as a case study 期刊论文 JOURNAL OF SEPARATION SCIENCE, 2021, 卷号: 44, 期号: 7, 页码: 1440-1451 作者:  Jin, Xu;  Zhang, Jianqing;  Li, Yun;  Wu, Wenyong;  Zhang, Hang 收藏  |  浏览/下载：62/0  |  提交时间：2021/05/24 authentication  multicriteria decision making  nontargeted metabolomics  quality markers  traditional Chinese medicine   Nontargeted metabolomic analysis and multiple criteria decision-making method induced robust quality markers screening for the authentication of herbal medicines from different origins by taking Ophiopogon japonicus (L. f.) Ker-Gawl. as a case study 期刊论文 JOURNAL OF SEPARATION SCIENCE, 2021, 页码: 12 作者:  Jin, Xu;  Zhang, Jianqing;  Li, Yun;  Wu, Wenyong;  Zhang, Hang 收藏  |  浏览/下载：57/0  |  提交时间：2021/05/24 authentication  multicriteria decision making  nontargeted metabolomics  quality markers  traditional Chinese medicine   Evenness is important in assessing progress towards sustainable development goals 期刊论文 NATIONAL SCIENCE REVIEW, 2021, 卷号: 8, 期号: 8 作者:  Liu, Yali;  Du, Jianqing;  Wang, Yanfen;  Cui, Xiaoyong;  Dong, Jichang 收藏  |  浏览/下载：35/0  |  提交时间：2021/11/18 sustainable development goals  evenness  development pathway  adaptive strategy  China